XPEV analyst estimates
XPeng (XPEV) analyst ratings, the average price target and its range, and every firm's latest call.
XPEV analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 23, 2026 | Goldman Sachs | XPeng price target lowered to $16 from $18 at Goldman Sachs | $16.00 |
| Sep 9, 2026 | UBS | XPeng price target lowered to $12 from $18 at UBS | $12.00 |
| Aug 25, 2026 | Barclays | XPeng (XPEV) PT Lowered to $14 at Barclays | $14.00 |
| Jul 16, 2026 | Barclays | XPeng price target lowered to $15 from $16 at Barclays | $15.00 |
| May 29, 2026 | Jefferies | XPeng (XPEV) PT Lowered to $25.20 at Jefferies | $25.20 |
| May 28, 2026 | Macquarie | XPeng upgraded to Outperform from Neutral at Macquarie | $19.00 |
| Feb 18, 2026 | Barclays | XPeng price target lowered to $17 from $20 at Barclays | $17.00 |
| Jan 15, 2026 | Macquarie | XPeng price target lowered to $26 from $32 at Macquarie | $26.00 |
| Jan 6, 2026 | Loop Capital Markets | Freedom Capital Markets Upgrades XPeng (XPEV) to Buy | $25.00 |
| Nov 11, 2025 | Morgan Stanley | XPeng (XPEV) PT Raised to $34 at Morgan Stanley | $34.00 |
| Jun 17, 2025 | Goldman Sachs | XPeng upgraded to Buy at Goldman as transformation 'starts to bear fruit' | $24.00 |
| Jun 12, 2025 | Morgan Stanley | XPeng price target raised to $28 from $26 at Morgan Stanley | $28.00 |
| May 22, 2025 | Bernstein | XPeng price target raised to $19 from $18 at Bernstein | $19.00 |
| May 21, 2025 | Macquarie | XPeng upgraded to Outperform at Macquarie after Q1 report | $24.00 |
| Mar 19, 2025 | Bernstein | XPeng price target raised to $18 from $14 at Bernstein | $18.00 |
- 4 firms rate XPEV: 2 buy, 1 hold, 1 sell.
- The average price target is $17.24 from 5 analysts, from $12.00 to $25.20.
Updated 2026-11-02 18:26 UTC